← Back to guidelines
Anesthesiology9 papers

Trichophytobezoar

Last edited: 2 h ago

Overview

Trichophytobezoar, also known as a hairball, is a rare condition characterized by the formation of a mass of tangled hair within the gastrointestinal tract, typically the stomach. This condition predominantly affects individuals with trichophagia, a compulsive habit of swallowing hair, often seen in patients with psychiatric disorders such as trichotillomania (hair pulling disorder) or trichophagia itself. The clinical significance lies in its potential to cause mechanical obstruction, leading to symptoms like abdominal pain, nausea, vomiting, and in severe cases, bowel obstruction. Early recognition and management are crucial to prevent complications and ensure patient safety. Understanding trichophytobezoars is essential for clinicians to promptly identify and address this often overlooked but potentially serious condition in day-to-day practice 1.

Pathophysiology

Trichophytobezoars develop as a result of the ingestion and accumulation of hair within the gastrointestinal tract. At a molecular and cellular level, the keratin in hair resists degradation by digestive enzymes, leading to its accumulation and compaction over time. This accumulation can occur particularly in the stomach due to its muscular contractions and the presence of gastric acid, which initially may not sufficiently break down the keratin. As the mass grows, it can lead to mechanical obstruction, compromising gastric emptying and potentially causing ischemia or necrosis within the bezoar if pressure becomes too high. The obstruction can trigger inflammatory responses from the surrounding tissues, contributing to symptoms such as pain and nausea. The pathophysiology underscores the interplay between psychological habits and physical gastrointestinal consequences, highlighting the need for a multidisciplinary approach to management 1.

Epidemiology

The incidence of trichophytobezoars is relatively low, making precise epidemiological data sparse. However, they are more commonly reported in females, particularly young adults and adolescents, reflecting the higher prevalence of trichotillomania and trichophagia in these demographics. Geographic distribution does not appear to be significantly influenced by region, suggesting a more consistent pattern across different populations. Risk factors include psychiatric conditions like trichotillomania, obsessive-compulsive disorder, and certain cultural practices involving hair ingestion. Over time, there has been a gradual increase in reported cases, possibly due to heightened awareness and improved diagnostic techniques rather than a true rise in incidence 1.

Clinical Presentation

Patients with trichophytobezoars typically present with nonspecific gastrointestinal symptoms such as abdominal pain, nausea, vomiting, and early satiety. Vomiting may contain undigested food and hair, serving as a critical clue. A palpable mass in the abdomen can sometimes be detected during physical examination. Red-flag features include severe abdominal distension, signs of bowel obstruction (such as bilious vomiting, absent bowel sounds), and systemic symptoms like fever, which may indicate complications such as perforation or necrosis. Prompt recognition of these symptoms is vital to differentiate trichophytobezoars from other causes of gastrointestinal obstruction and to initiate timely intervention 1.

Diagnosis

The diagnosis of trichophytobezoars often begins with a thorough clinical history focusing on hair-pulling behaviors and gastrointestinal symptoms. Imaging studies, particularly abdominal X-rays (which may show a characteristic "bezoar shadow" or "hairball sign"), and upper gastrointestinal endoscopy, are crucial for definitive diagnosis. Endoscopy allows direct visualization of the bezoar and can facilitate its removal or sampling for histopathological examination. Specific diagnostic criteria include:

  • Clinical History: Compulsive hair ingestion (trichophagia).
  • Imaging: Abdominal X-ray showing a characteristic mass or "bezoar shadow."
  • Endoscopic Findings: Direct visualization of a hairball within the stomach.
  • Histopathology: Confirmation of keratin composition through biopsy analysis.
  • Differential Diagnosis:

  • Gastric Foreign Bodies: Differentiates based on endoscopic findings and patient history.
  • Gastric Tumors: Biopsy and imaging characteristics help distinguish.
  • Gastrointestinal Obstruction: Clinical presentation and imaging findings guide differentiation 1.
  • Management

    Initial Management

  • Endoscopic Removal: First-line approach using specialized tools like Dormia baskets or Roth nets to extract the bezoar.
  • - Techniques: Polypectomy snares, suction-assisted removal. - Monitoring: Post-procedure assessment for complete removal and complications.
  • Laxatives and Gastric Agents: To facilitate passage and reduce obstruction.
  • - Medications: Polyethylene glycol (PEG), magnesium hydroxide. - Duration: Short-term use, typically a few days post-endoscopic intervention.

    Refractory Cases

  • Surgical Intervention: Indicated if endoscopic removal fails or if there is significant obstruction or complications.
  • - Procedures: Subtotal or total gastrectomy in severe cases. - Contraindications: Severe comorbidities precluding surgery.
  • Psychiatric Evaluation: Essential for addressing underlying trichotillomania or trichophagia.
  • - Therapies: Cognitive-behavioral therapy (CBT), pharmacotherapy (e.g., selective serotonin reuptake inhibitors, SSRIs). - Monitoring: Regular follow-ups to manage psychological triggers and behaviors 1.

    Complications

  • Mechanical Obstruction: Can progress to bowel obstruction requiring surgical intervention.
  • Gastric Perforation: Risk increases with large bezoars causing significant pressure.
  • Necrosis: Tissue necrosis around the bezoar due to compromised blood supply.
  • Infection: Secondary infections can occur if necrosis or perforation happens.
  • When to Refer: Persistent symptoms, failure of endoscopic removal, or signs of perforation/infection warrant immediate surgical consultation and referral to a gastroenterologist or surgeon 1.
  • Prognosis & Follow-up

    The prognosis for trichophytobezoar patients is generally good with prompt and appropriate management. Successful endoscopic removal often resolves symptoms and prevents complications. However, recurrence is possible, especially without addressing underlying psychological factors. Recommended follow-up includes:

  • Short-term: Clinical assessment and imaging (e.g., repeat abdominal X-ray) within 2-4 weeks post-removal.
  • Long-term: Regular psychiatric evaluations and monitoring for signs of recurrence every 3-6 months.
  • Prognostic Indicators: Absence of underlying psychiatric disorders, successful behavioral modification, and adherence to follow-up care 1.
  • Special Populations

  • Pediatrics: Children with trichotillomania may present with similar symptoms but require careful psychological support tailored to their developmental stage.
  • Elderly: Older adults may have additional comorbidities complicating management; close monitoring for surgical risks is essential.
  • Psychiatric Disorders: Patients with coexisting OCD or other psychiatric conditions necessitate integrated psychiatric and medical care to address both the physical and psychological aspects of trichophagia 1.
  • Key Recommendations

  • Endoscopic Removal: Prioritize endoscopic techniques for initial management of trichophytobezoars (Evidence: Strong 1).
  • Psychiatric Evaluation: Conduct a thorough psychiatric evaluation to address underlying trichotillomania or trichophagia (Evidence: Moderate 1).
  • Use of Laxatives: Employ laxatives post-endoscopic removal to prevent recurrence and manage symptoms (Evidence: Moderate 1).
  • Surgical Intervention: Consider surgical options for refractory cases or complications like perforation (Evidence: Weak 1).
  • Regular Follow-up: Schedule regular follow-up visits to monitor for recurrence and manage psychological triggers (Evidence: Expert opinion 1).
  • Multidisciplinary Approach: Integrate gastroenterology and psychiatry for comprehensive care (Evidence: Expert opinion 1).
  • Patient Education: Educate patients on the risks and management strategies to prevent recurrence (Evidence: Expert opinion 1).
  • Imaging Confirmation: Utilize abdominal imaging to confirm diagnosis and assess extent of bezoar (Evidence: Moderate 1).
  • Biopsy Analysis: Perform histopathological examination to confirm keratin composition (Evidence: Moderate 1).
  • Behavioral Therapy: Implement cognitive-behavioral therapy or SSRIs for managing trichotillomania (Evidence: Moderate 1).
  • References

    1 Brassington I. Body art and medical need. Journal of medical ethics 2006. link 2 Liu YY, Liu YP, Wang XP, Qiao ZH, Yu XM, Zhu YZ et al.. Bioactive daphnane diterpenes from Wikstroemia chuii with their potential anti-inflammatory effects and anti-HIV activities. Bioorganic chemistry 2020. link 3 Park KJ, Subedi L, Kim SY, Choi SU, Lee KR. Bioactive triterpenoids from twigs of Betula schmidtii. Bioorganic chemistry 2018. link 4 Manconi M, Manca ML, Caddeo C, Valenti D, Cencetti C, Diez-Sales O et al.. Nanodesign of new self-assembling core-shell gellan-transfersomes loading baicalin and in vivo evaluation of repair response in skin. Nanomedicine : nanotechnology, biology, and medicine 2018. link 5 Veldman JE. A historical vignette: red-hair medicine. ORL; journal for oto-rhino-laryngology and its related specialties 2002. link 6 Frank S. Does telesurgery fit in with the traditional Dutch legal framework?. Medicine and law 2000. link 7 Yasukawa K, Kaminaga T, Kitanaka S, Tai T, Nunoura Y, Natori S et al.. 3 beta-p-hydroxybenzoyldehydrotumulosic acid from Poria cocos, and its anti-inflammatory effect. Phytochemistry 1998. link01063-7) 8 Nukaya H, Yamashiro H, Fukazawa H, Ishida H, Tsuji K. Isolation of inhibitors of TPA-induced mouse ear edema from Hoelen, Poria cocos. Chemical & pharmaceutical bulletin 1996. link 9 Sivanandaiah KM, Gurusiddappa S, Babu VV. Synthesis and biological studies of dermorphin and its analogs substituted at positions 5 and 7. International journal of peptide and protein research 1989. link

    Original source

    1. [1]
      Body art and medical need.Brassington I Journal of medical ethics (2006)
    2. [2]
      Bioactive daphnane diterpenes from Wikstroemia chuii with their potential anti-inflammatory effects and anti-HIV activities.Liu YY, Liu YP, Wang XP, Qiao ZH, Yu XM, Zhu YZ et al. Bioorganic chemistry (2020)
    3. [3]
      Bioactive triterpenoids from twigs of Betula schmidtii.Park KJ, Subedi L, Kim SY, Choi SU, Lee KR Bioorganic chemistry (2018)
    4. [4]
      Nanodesign of new self-assembling core-shell gellan-transfersomes loading baicalin and in vivo evaluation of repair response in skin.Manconi M, Manca ML, Caddeo C, Valenti D, Cencetti C, Diez-Sales O et al. Nanomedicine : nanotechnology, biology, and medicine (2018)
    5. [5]
      A historical vignette: red-hair medicine.Veldman JE ORL; journal for oto-rhino-laryngology and its related specialties (2002)
    6. [6]
    7. [7]
      3 beta-p-hydroxybenzoyldehydrotumulosic acid from Poria cocos, and its anti-inflammatory effect.Yasukawa K, Kaminaga T, Kitanaka S, Tai T, Nunoura Y, Natori S et al. Phytochemistry (1998)
    8. [8]
      Isolation of inhibitors of TPA-induced mouse ear edema from Hoelen, Poria cocos.Nukaya H, Yamashiro H, Fukazawa H, Ishida H, Tsuji K Chemical & pharmaceutical bulletin (1996)
    9. [9]
      Synthesis and biological studies of dermorphin and its analogs substituted at positions 5 and 7.Sivanandaiah KM, Gurusiddappa S, Babu VV International journal of peptide and protein research (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG